FCGR3A and hematocrit: M1 and M3, which were dominant in the PBMCs of HT patients, abundantly expressed CD14 or FCGR3A (CD16) and were considered as classical CD14+ monocytes and non-classical CD16+ monocytes, respectively (Fig. 8a–c).